Basic Information
RNALocate ID: RLID:01001456
RNA Symbol: hsa-miR-103a-3p
Localization: Cytoplasm
RNA Information
RNA Name: hsa-miR-103
RNA ID: miRBase:MIMAT0000101
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 21695135
Tissue/Cell Line: Cell line (HeLa)
Method: Microarray

Heatmap showing the 57 miRNAs differentially expressed in HeLa cells from mitochondrial and cytosolic RNA. Three independent microarray profiling experiments (microarray n1, n2 and n3) are shown and reproducibly revealed 13 miRNAs enriched in mitochondrial RNA.

Originally published in PLoS One. Bandiera S, et al, 2011. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)
Description: While 44 miRNAs showed a greater enrichment in the cytosolic Hy3-labeled RNA fraction, 13 miRNAs were significantly and reproducibly enriched in the mitochondrial Hy5-labeled RNA sample (ranging from 1.5- to 56-fold), namely hsa-miR-1973, hsa-miR-1275, hsa-miR-494, hsa-miR-513a-5p, hsa-miR-1246, hsa-miR-328, hsa-miR-1908, hsa-miR-1972, hsa-miR-1974, hsa-miR-1977, hsa-miR-638, hsa-miR-1978 and hsa-miR-1201 (Figure 5A). Data are collected from Figure 5.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001454 Cytoplasm Nasopharyngeal carcinoma cells 20498841
RLID:01001455 Cytoplasm Neural progenitor cells 21363885
RLID:01001457 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001458 Mitochondrion Myotube|Osteosarcoma cell line (143B) 27396686
RLID:01001459 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001460 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01001461 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001462 Nucleolus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001463 Nucleus Nasopharyngeal carcinoma cells 20498841
RLID:01001464 Nucleus Colon adenocarcinoma cells 20864815
RLID:11001017 Exosome Human cervical cancer cell line (HeLa) 25760330
RLID:11001018 Exosome Pooled sera 27278097
RLID:11001019 Exosome Serum 18589210
RLID:11001020 Exosome Peripheral blood mononuclear cells 19002258
RLID:11001021 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11001022 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11001023 Exosome Brain tissue 23382797
RLID:11001024 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001025 Microvesicle Plasma 19002258
RLID:11001026 Microvesicle Plasma 23077538
RLID:11001027 Microvesicle Seminal plasma 23539611
RLID:11001028 Microvesicle Follicular fluid 23666971
RLID-D:11000035 Exosome Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue
RLID-D:11000300 Microvesicle Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-103a-3p Splenic marginal zone lymphoma MNDR-E-MI-02946
MNDR hsa-miR-103a-3p Oral squamous cell carcinoma MNDR-E-MI-02947
MNDR hsa-miR-103a-3p Large cell neuroendocrine cancer MNDR-E-MI-02948
MNDR hsa-miR-103a-3p Medulloblastoma MNDR-E-MI-02949
MNDR hsa-miR-103a-3p High-grade serous ovarian carcinoma MNDR-E-MI-02950
MNDR hsa-miR-103a-3p Ovarian clear cell carcinoma MNDR-E-MI-02951
MNDR hsa-miR-103a-3p Uterine corpus endometrial carcinoma MNDR-E-MI-02952
MNDR hsa-miR-103a-3p Lymphoma MNDR-E-MI-02953
MNDR hsa-miR-103a-3p Lymphoma non-hodgkin MNDR-E-MI-02954
MNDR hsa-miR-103a-3p Estrogen-receptor positive breast cancer MNDR-E-MI-02955
MNDR hsa-miR-103a-3p Estrogen-receptor negative breast cancer MNDR-E-MI-02956
MNDR hsa-miR-103a-3p Progesterone-receptor positive breast cancer MNDR-E-MI-02957
MNDR hsa-miR-103a-3p Progesterone-receptor negative breast cancer MNDR-E-MI-02958
MNDR hsa-miR-103a-3p Her2-receptor positive breast cancer MNDR-E-MI-02959
MNDR hsa-miR-103a-3p Breast cancer luminal MNDR-E-MI-02960
MNDR hsa-miR-103a-3p Anencephaly MNDR-E-MI-02961
MNDR hsa-miR-103a-3p Niemann-pick disease type c MNDR-E-MI-02962
MNDR hsa-miR-103a-3p Neurofibromatosis 1 MNDR-E-MI-02963
MNDR hsa-miR-103a-3p Dermatomyositis MNDR-E-MI-02964
MNDR hsa-miR-103a-3p Prostate cancer MNDR-E-MI-02965
MNDR hsa-miR-103a-3p Gastric cancer MNDR-E-MI-02966
MNDR hsa-miR-103a-3p Gastric lymphoma MNDR-E-MI-02967
MNDR hsa-miR-103a-3p Alzheimer disease MNDR-E-MI-02968
MNDR hsa-miR-103a-3p Intracranial aneurysm MNDR-E-MI-02969
MNDR hsa-miR-103a-3p Bladder cancer MNDR-E-MI-02970
MNDR hsa-miR-103a-3p Esophageal carcinoma MNDR-E-MI-02971
MNDR hsa-miR-103a-3p Dysautonomia familial MNDR-E-MI-02972
MNDR hsa-miR-103a-3p Head and neck cancer MNDR-E-MI-02973
MNDR hsa-miR-103a-3p Malaria MNDR-E-MI-02974
MNDR hsa-miR-103a-3p Leukemia MNDR-E-MI-02975
MNDR hsa-miR-103a-3p Huntington disease MNDR-E-MI-02976
MNDR hsa-miR-103a-3p Chorea MNDR-E-MI-02977
MNDR hsa-miR-103a-3p Cardiovascular disease MNDR-E-MI-02978
MNDR hsa-miR-103a-3p Carotid stenosis MNDR-E-MI-02979
MNDR hsa-miR-103a-3p Moyamoya disease MNDR-E-MI-02980
MNDR hsa-miR-103a-3p Lung cancer MNDR-E-MI-02981
MNDR hsa-miR-103a-3p Endometrial cancer MNDR-E-MI-02982
MNDR hsa-miR-103a-3p Parkinson disease MNDR-E-MI-02983
MNDR hsa-miR-103a-3p Niemann-pick disease MNDR-E-MI-02984
MNDR hsa-miR-103a-3p Basal-like breast cancer MNDR-E-MI-02985
MNDR hsa-miR-103a-3p Thyroid cancer MNDR-E-MI-02986
MNDR hsa-miR-103a-3p Pituitary neoplasms MNDR-E-MI-02987
MNDR hsa-miR-103a-3p Malignant mesothelioma MNDR-E-MI-02988
MNDR hsa-miR-103a-3p Pancreatic cancer MNDR-E-MI-02989
MNDR hsa-miR-103a-3p Melanoma MNDR-E-MI-02990
MNDR hsa-miR-103a-3p Nephroblastoma MNDR-E-MI-02991
MNDR hsa-miR-103a-3p Colon cancer MNDR-E-MI-02992
MNDR hsa-miR-103a-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-02993
MNDR hsa-miR-103a-3p Prostate adenocarcinoma MNDR-E-MI-02994
MNDR hsa-miR-103a-3p Cerebellar disease MNDR-E-MI-02995
MNDR hsa-miR-103a-3p Carcinoma ductal breast MNDR-E-MI-02996
MNDR hsa-miR-103a-3p Glioblastoma MNDR-E-MI-02997
MNDR hsa-miR-103a-3p Glioma MNDR-E-MI-02998
MNDR hsa-miR-103a-3p Chordoma MNDR-E-MI-02999
MNDR hsa-miR-103a-3p Amyotrophic lateral sclerosis MNDR-E-MI-03000
MNDR hsa-miR-103a-3p Epilepsy temporal lobe MNDR-E-MI-03001
MNDR hsa-miR-103a-3p Osteosarcoma MNDR-E-MI-03002
MNDR hsa-miR-103a-3p Inclusion body myositis MNDR-E-MI-03003
MNDR hsa-miR-103a-3p Meningioma MNDR-E-MI-03004
MNDR hsa-miR-103a-3p Liver cancer MNDR-E-MI-03005
MNDR hsa-miR-103a-3p Uterine cancer MNDR-E-MI-03006
MNDR hsa-miR-103a-3p Gastric adenocarcinoma MNDR-E-MI-03007
MNDR hsa-miR-103a-3p Pituitary adenoma MNDR-E-MI-03008
MNDR hsa-miR-103a-3p Lung squamous cell carcinoma MNDR-E-MI-03009
MNDR hsa-miR-103a-3p Carcinoma lung non-small-cell MNDR-E-MI-03010
MNDR hsa-miR-103a-3p Lung adenocarcinoma MNDR-E-MI-03011
MNDR hsa-miR-103a-3p Adrenocortical cancer MNDR-E-MI-03012
MNDR hsa-miR-103a-3p Thyroid carcinoma MNDR-E-MI-03013
MNDR hsa-miR-103a-3p Ovarian carcinoma MNDR-E-MI-03014
MNDR hsa-miR-103a-3p Bladder urothelial carcinoma MNDR-E-MI-03015
MNDR hsa-miR-103a-3p Pancreatic adenocarcinoma MNDR-E-MI-03016
MNDR hsa-miR-103a-3p Carcinoma renal cell MNDR-E-MI-03017
MNDR hsa-miR-103a-3p Kidney renal papillary cell carcinoma MNDR-E-MI-03018
MNDR hsa-miR-103a-3p Renal clear cell carcinoma MNDR-E-MI-03019
MNDR hsa-miR-103a-3p Cholangiocarcinoma MNDR-E-MI-03020
MNDR hsa-miR-103a-3p Esophageal cancer MNDR-E-MI-03021
MNDR hsa-miR-103a-3p Liver cirrhosis MNDR-E-MI-03022
MNDR hsa-miR-103a-3p Lung small cell carcinoma MNDR-E-MI-03023
MNDR hsa-miR-103a-3p Encephalopathy bovine spongiform MNDR-E-MI-03024
MNDR hsa-miR-103a-3p Synovial sarcoma MNDR-E-MI-03025
MNDR hsa-miR-103a-3p Head and neck squamous cell carcinoma MNDR-E-MI-03026
MNDR hsa-miR-103a-3p Growth hormone-secreting pituitary adenoma MNDR-E-MI-03027
MNDR hsa-miR-103a-3p Fibromyalgia MNDR-E-MI-03028
MNDR hsa-miR-103a-3p Encephalomyelitis MNDR-E-MI-03029
MNDR hsa-miR-103a-3p Breast invasive carcinoma MNDR-E-MI-03030
MNDR hsa-miR-103a-3p Hepatocellular carcinoma MNDR-E-MI-03031
MNDR hsa-miR-103a-3p B-cell lymphoma MNDR-E-MI-03032
MNDR hsa-miR-103a-3p Rheumatoid arthritis MNDR-E-MI-03033
MNDR hsa-miR-103a-3p T-cell leukemia MNDR-E-MI-03034
MNDR hsa-miR-103a-3p Retinoblastoma MNDR-E-MI-03035
MNDR hsa-miR-103a-3p Neuroblastoma MNDR-E-MI-03036
MNDR hsa-miR-103a-3p Chronic fatigue syndrome MNDR-E-MI-03037
MNDR hsa-miR-103a-3p Hodgkin lymphoma MNDR-E-MI-03038
MNDR hsa-miR-103a-3p Burkitt lymphoma MNDR-E-MI-03039
MNDR hsa-miR-103a-3p Dementia vascular MNDR-E-MI-03040
MNDR hsa-miR-103a-3p Tonsil cancer MNDR-E-MI-03041
MNDR hsa-miR-103a-3p Acute myeloid leukemia MNDR-E-MI-03042
MNDR hsa-miR-103a-3p Colorectal cancer MNDR-E-MI-03043
MNDR hsa-miR-103a-3p Nasopharynx carcinoma MNDR-E-MI-03044
MNDR hsa-miR-103a-3p Multiple myeloma MNDR-E-MI-03045
MNDR hsa-miR-103a-3p Ovarian epithelial cancer MNDR-E-MI-03046
MNDR hsa-miR-103a-3p Cardiomegaly MNDR-E-MI-03047
MNDR hsa-miR-103a-3p Nasopharyngeal cancer MNDR-E-MI-03048
MNDR hsa-miR-103a-3p Prostatic neoplasms MNDR-E-MI-03049
MNDR hsa-miR-103a-3p Pseudorabies MNDR-E-MI-03050
MNDR hsa-miR-103a-3p Sleep deprivation MNDR-E-MI-03051
MNDR hsa-miR-103a-3p Epstein-barr virus infections MNDR-E-MI-03052
MNDR hsa-miR-103a-3p Cerebral hemorrhage traumatic MNDR-E-MI-03053
MNDR hsa-miR-103a-3p Intracranial hemorrhage hypertensive MNDR-E-MI-03054
MNDR hsa-miR-103a-3p Venous thromboembolism MNDR-E-MI-03055
MNDR hsa-miR-103a-3p Stroke lacunar MNDR-E-MI-03056
MNDR hsa-miR-103a-3p Non-alcoholic fatty liver disease MNDR-E-MI-03057
MNDR hsa-miR-103a-3p Breast cancer her3+ negative MNDR-E-MI-03058
MNDR hsa-miR-103a-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-03059
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter AADAT Homo sapiens RR00020840
TOP